Experiences with
Cancer and tumours54,727 public posts
Want to take advantage of all our features? Just log in!
or
Mirvetuximab soravtansine - your experiences needed
Dear All
We have been asked by the National Institute of Health and Care Excellence (NICE) to make a submission as part of their assessment for Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer